Effect of interferon administration on pulmonary osteogenic sarcomas in an experimental murine model
- PMID: 6166780
Effect of interferon administration on pulmonary osteogenic sarcomas in an experimental murine model
Abstract
The iv inoculation of a suspension of osteogenic sarcoma cells induced metastatic tumor nodules in the lungs of C57BL/6 mice. The administration of 50,000-100,000 U of interferon daily for 7 days strikingly reduced the tumor mass in the lung and the number of tumor nodules present in histopathologic sections when the interferon treatment was initiated immediately after tumor cell inoculation. In some animals the development of any detectable metastatic lesion was completely prevented. Extending the therapy form 7 days to 21 days failed to improve the protective effect. Interferon therapy delayed until 7 days after tumor cell inoculation had no effect. These findings indicate the effectiveness of exogenous interferon in this murine osteogenic sarcoma model when interferon treatment is initiated within 1 hour of tumor cell inoculation, but not when it is delayed until tumor nodules are established in the lungs.
Similar articles
-
The antitumor effect of interferon against murine osteogenic sarcoma.Nihon Seikeigeka Gakkai Zasshi. 1983 Feb;57(2):199-213. Nihon Seikeigeka Gakkai Zasshi. 1983. PMID: 6189927
-
Inhibition of murine osteogenic sarcomas by treatment with type I or type II interferon.J Natl Cancer Inst. 1978 Sep;61(3):871-4. J Natl Cancer Inst. 1978. PMID: 278865
-
A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.Hum Gene Ther. 2001 Aug 10;12(12):1591-3. Hum Gene Ther. 2001. PMID: 11529247 Clinical Trial.
-
Interferon treatment of human neoplasia.Adv Cancer Res. 1986;46:1-265. Adv Cancer Res. 1986. PMID: 2425561 Review. No abstract available.
-
[The role of interferon in anti-tumor resistance].Eksp Onkol. 1989;11(6):49-54. Eksp Onkol. 1989. PMID: 2479513 Review. Russian.
Cited by
-
Effect of interleukin-18 on metastasis of mouse osteosarcoma cells.Cancer Immunol Immunother. 2006 Sep;55(9):1151-8. doi: 10.1007/s00262-005-0097-3. Epub 2006 Jan 12. Cancer Immunol Immunother. 2006. PMID: 16408211 Free PMC article.
-
Interferon enhancement of the invasive capacity of Ewing sarcoma cells in vitro.Proc Natl Acad Sci U S A. 1982 Jul;79(13):4064-8. doi: 10.1073/pnas.79.13.4064. Proc Natl Acad Sci U S A. 1982. PMID: 6180434 Free PMC article.
-
Regulation of interferon pathway in 2-methoxyestradiol-treated osteosarcoma cells.BMC Cancer. 2012 Mar 19;12:93. doi: 10.1186/1471-2407-12-93. BMC Cancer. 2012. PMID: 22429849 Free PMC article.
-
Human interferons inhibit experimental metastases of a human melanoma cell line in nude mice.Br J Cancer. 1988 Sep;58(3):350-4. doi: 10.1038/bjc.1988.217. Br J Cancer. 1988. PMID: 2460119 Free PMC article.
-
Time-dependent suppression of melanoma metastases and natural killer cell activation by interferon.Arch Dermatol Res. 1986;278(4):329-34. doi: 10.1007/BF00407748. Arch Dermatol Res. 1986. PMID: 3740943
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical